|
Efficacy outcomes with bevacizumab added to chemotherapy (bev+CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC). |
|
|
Consulting or Advisory Role - Amgen; Bayer; Sanofi |
Speakers' Bureau - Amgen; Bayer; Roche; Sanofi |
Research Funding - Amgen (Inst); Bayer (Inst); Merck Serono (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I) |
Research Funding - Taiho Pharmaceutical |
|
|
Honoraria - Bayer; Roche; Sanofi; Servier; Terumo |
Consulting or Advisory Role - Bayer; Lilly; Roche; Servier |
|
|
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst) |
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme |
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - Merck; Roche; Vertex |
|
|
|
|
|
|
|
Stock and Other Ownership Interests - Roche |
|
Consulting or Advisory Role - Roche |
|
Travel, Accommodations, Expenses - Roche |
Other Relationship - Roche |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche |